日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: insights from a multicenter case series

BCMA靶向CAR-T细胞治疗后免疫效应细胞相关性肠炎:来自多中心病例系列的启示

Susanibar-Adaniya, Sandra; Derman, Benjamin A; Cohen, Adam D; Vogl, Dan T; Richard, Shambavi; Rossi, Adriana; Frigualt, Matthew J; Yee, Andrew J; Dhakal, Binod; Bar, Noffar

Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)-real world experience from the US multiple myeloma immunotherapy consortium

干细胞增强疗法 (SCB) 对嵌合抗原受体 T 细胞疗法 (CAR-T) 相关血液毒性在复发/难治性多发性骨髓瘤 (RRMM) 患者中的疗效——来自美国多发性骨髓瘤免疫治疗联盟的真实世界经验

Varga, Cindy; Robinson, Myra; Davis, James A; Hashmi, Hamza; Martin, Thomas G; Kumar, Anupama; Sborov, Douglas W; Wagner, Charlotte B; Hansen, Doris K; Castaneda Puglianini, Omar; Shune, Leyla; Bhurtel, Evgeunia; Afrough, Aimaz; Anderson, Larry D Jr; Dhakal, Binod; Herr, Megan M; Richard, Shambavi; Lieberman-Cribbin, Alex; Sherbenou, Daniel; Forsberg, Peter A; Purvey, Sneha; Khouri, Jack; Lin, Yi; Sidana, Surbhi; Patel, Krina K; Kocoglu, Mehmet; Midha, Shonali; Ferreri, Christopher J

Safety and efficacy of BCMA CAR-T vs. bispecific antibodies in patients with relapsed multiple myeloma: a systematic review and meta-analysis

BCMA CAR-T 与双特异性抗体治疗复发性多发性骨髓瘤患者的安全性和有效性:系统评价和荟萃分析

Vandenboom, Hayley; Akhtar, Othman; Szabo, Aniko; Narra, Ravi; Mohan, Meera; D'Souza, Anita; Pasquini, Marcelo; Dhakal, Binod

Plasma cell leukemia: genomic features and their potential relevance for exploring clinical actionability

浆细胞白血病:基因组特征及其在探索临床可操作性方面的潜在意义

Mohan, Meera; Danziger, Natalie; Akhtar, Othman Salim; Narra, Ravi; Pasquini, Marcello C; Radhakrishnan, Sabarinath; Dhakal, Binod; D'Souza, Anita; Lin, Douglas; Ho, Caleb; Kurzrock, Razelle

Fine Mapping of MHC Region Identifies Novel Susceptibility Loci in Multiple Myeloma When Comparing With Its Precursor Monoclonal Gammopathy of Unknown Significance

与前体单克隆丙种球蛋白病相比,MHC区域的精细定位鉴定出多发性骨髓瘤的新易感基因位点

Arsang-Jang, Shahram; Massat, Ben; Pareek, Gokul; Han, Jing; Thapa, Bicky; Patek, Victoria; Nader, Zeina; Auer, Paul L; Zimmerman, Michael T; Urrutia, Raul; Hari, Parameswaran; D'Souza, Anita; Dhakal, Binod; Janz, Siegfried; Dong, Jing

Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma

复发/难治性多发性骨髓瘤标准治疗方案 Idecabtagene Vicleucel 与 Ciltacabtagene Autoleucel 的比较

Hansen, Doris K; Peres, Lauren C; Dima, Danai; Richards, Alicia; Shune, Leyla; Afrough, Aimaz; Midha, Shonali; Dhakal, Binod; Kocoglu, Mehmet H; Atrash, Shebli; Ferreri, Christopher; Castaneda, Omar; Davis, James A; Bhurtel, Evguenia; McGuirk, Joseph; Wagner, Charlotte; Bansal, Radhika; Costello, Patrick; Smith, Kinaya; Lieberman-Cribbin, Alex; De Avila, Gabriel; Purvey, Sneha; Hosoya, Hitomi; Mikkilineni, Lekha; Oswald, Laura B; Kaur, Gurbakhash; Pasvolsky, Oren; Gaballa, Mahmoud; Herr, Megan M; Forsberg, Peter; Janakiram, Murali; Htut, Myo; Asoori Maringanti, Sireesha; Kalariya, Nilesh; Hashmi, Hamza; Reshef, Ran; Sborov, Douglas W; Nadeem, Omar; Anwer, Faiz; Khouri, Jack; Raza, Shahzad; Atanackovic, Djordje; Alsina, Melissa; Freeman, Ciara L; Locke, Frederick L; Voorhees, Peter; Anderson, Larry D Jr; Richard, Shambavi; Martin, Thomas; Lin, Yi; Patel, Krina K; Sidana, Surbhi

Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma

在 CARTITUDE-1 研究中,接受 Ciltacabtagene Autoleucel 治疗的复发/难治性多发性骨髓瘤患者获得长期(≥5 年)缓解和生存。

Jagannath, Sundar; Martin, Thomas G; Lin, Yi; Cohen, Adam D; Raje, Noopur; Htut, Myo; Deol, Abhinav; Agha, Mounzer; Berdeja, Jesus G; Lesokhin, Alexander M; Liegel, Jessica J; Rossi, Adriana; Lieberman-Cribbin, Alex; Usmani, Saad Z; Dhakal, Binod; Parekh, Samir; Li, Hui; Wang, Feng; Montes de Oca, Rocio; Plaks, Vicki; Sun, Huabin; Banerjee, Arnob; Schecter, Jordan M; Lendvai, Nikoletta; Madduri, Deepu; Lengil, Tamar; Zhu, Jieqing; Koneru, Mythili; Akram, Muhammad; Patel, Nitin; Costa Filho, Octavio; Jakubowiak, Andrzej J; Voorhees, Peter M

Standard-of-care idecabtagene vicleucel for relapsed/refractory multiple myeloma

复发/难治性多发性骨髓瘤的标准治疗方案idecabtagene vicleucel

Sidana, Surbhi; Ahmed, Nausheen; Akhtar, Othman Salim; Brazauskas, Ruta; Oloyede, Temitope; Bye, Matthew; Hansen, Doris; Ferreri, Christopher; Freeman, Ciara L; Afrough, Aimaz; Anderson, Larry D Jr; Dhakal, Binod; Dhanda, Devender; Gowda, Lohith; Hashmi, Hamza; Harrison, Melanie J; Kitali, Amani; Landau, Heather; Mirza, Abu-Sayeef; Patwardhan, Pallavi; Qazilbash, Muzaffar; Usmani, Saad; Patel, Krina; Nishihori, Taiga; Ganguly, Siddhartha; Pasquini, Marcelo C

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

标准疗法 ciltacabtagene autoleucel 治疗复发/难治性多发性骨髓瘤的安全性和有效性

Sidana, Surbhi; Patel, Krina K; Peres, Lauren C; Bansal, Radhika; Kocoglu, Mehmet H; Shune, Leyla; Atrash, Shebli; Smith, Kinaya; Midha, Shonali; Ferreri, Christopher; Dhakal, Binod; Dima, Danai; Costello, Patrick; Wagner, Charlotte; Reshef, Ran; Hosoya, Hitomi; Mikkilineni, Lekha; Atanackovic, Djordje; Chhabra, Saurabh; Parrondo, Ricardo; Nadeem, Omar; Mann, Hashim; Kalariya, Nilesh; Hovanky, Vanna; De Avila, Gabriel; Freeman, Ciara L; Locke, Frederick L; Alsina, Melissa; Wong, Sandy; Herr, Megan; Htut, Myo; McGuirk, Joseph; Sborov, Douglas W; Khouri, Jack; Martin, Thomas; Janakiram, Murali; Lin, Yi; Hansen, Doris K

Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy

四联疗法治疗新诊断的多发性骨髓瘤中孤立性微小残留病进展的意义

Costa, Luciano J; Medvedova, Eva; Dhakal, Binod; Dholaria, Bhagirathbhai R; Godby, Kelly N; Bal, Susan; Ravi, Gayathri; Giri, Smith; Chhabra, Saurabh; Silbermann, Rebecca; Callander, Natalie S